Monday, January 20, 2020

NEWSROOM

Mental Health Professionals and Patients Often Disagree on Causes of Symptoms

A new study finds that clinicians’ disregard for mental health patients’ insight into their own condition may be detrimental to treatment.

The Charade of New Drug Approvals for Schizophrenia

The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.
digital antipsychotic

The Rise of the Digital Asylum

Mad Pride Rises in Mexico

FDA Approves Drugs Faster Than Ever but Relies on Weaker Evidence

From NPR: Almost half of recent new drug approvals were based on only one pivotal clinical trial instead of the two or more that used to be the norm.